Answers are grounded in this paper and cite their sources.
Randomized trial explores cannabinoids' effectiveness in treating epilepsy, suggesting potential clinical value.
The pharmacologic and biochemical features of cannabinoids make them candidates for antiseizure medications. At this time, anecdotes have outstripped controlled clinical trials as sources of support for their clinical value.
No takes yet. Share an insight, caveat, or question.
Friedman et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: